Abstract
The transglutaminases (TGase; EC2.3.2.13) (R-glutaminyl-peptide-aminase- -glutamyltransferase) are a family of enzymes that catalyse post-translational modifications in proteins, producing covalent amide bonds between a primary amine group in a polyamine or lysine (amine donor), and a γ -carboxamide group of the glutamyl residue of some proteins (amine receptor). These enzymes were detected for the first time in animals, where they modify structural proteins, and are widely distributed in bacteria, animals, and plants. Of all the reactions that are catalysed by TGases, protein cross linking has probably attracted the greatest interest owing the industrial applications of these catalytic reactions. A review of the patents related to the different cloned TGases and its putative applications in medicine, food processing, and other applications as polymer obtaining, etc., is presented here. Due to the widespread number of recently published patents about this enzyme, a classification in relation to a) species origin and b) application field, is presented.
Keywords: Transglutaminase enzyme, cross-linking, gene cloning, structural proteins, lysine, polyamines, biomedicine, biomaterials, food processing, antibodies
Recent Patents on Biotechnology
Title: Recent Patents on Transglutaminase Production and Applications: A Brief Review
Volume: 3 Issue: 3
Author(s): Mireya Santos and J. M. Torne
Affiliation:
Keywords: Transglutaminase enzyme, cross-linking, gene cloning, structural proteins, lysine, polyamines, biomedicine, biomaterials, food processing, antibodies
Abstract: The transglutaminases (TGase; EC2.3.2.13) (R-glutaminyl-peptide-aminase- -glutamyltransferase) are a family of enzymes that catalyse post-translational modifications in proteins, producing covalent amide bonds between a primary amine group in a polyamine or lysine (amine donor), and a γ -carboxamide group of the glutamyl residue of some proteins (amine receptor). These enzymes were detected for the first time in animals, where they modify structural proteins, and are widely distributed in bacteria, animals, and plants. Of all the reactions that are catalysed by TGases, protein cross linking has probably attracted the greatest interest owing the industrial applications of these catalytic reactions. A review of the patents related to the different cloned TGases and its putative applications in medicine, food processing, and other applications as polymer obtaining, etc., is presented here. Due to the widespread number of recently published patents about this enzyme, a classification in relation to a) species origin and b) application field, is presented.
Export Options
About this article
Cite this article as:
Santos Mireya and Torne M. J., Recent Patents on Transglutaminase Production and Applications: A Brief Review, Recent Patents on Biotechnology 2009; 3 (3) . https://dx.doi.org/10.2174/187220809789389180
DOI https://dx.doi.org/10.2174/187220809789389180 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monocarboxylate Transporter 1 in Brain Diseases and Cancers
Current Drug Metabolism The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer’s Dementia Using the NACC Database
Current Alzheimer Research Progress and Prospects of Stem Cells in Treatment of Drug Resistant Tuberculosis
Current Respiratory Medicine Reviews Targeting the Akt-pathway to Improve Radiosensitivity in Glioblastoma
Current Pharmaceutical Design Editorial [Hot Topic: Alzheimers Disease: Highlights from Research on Hormones, Growth Factors and Signaling Pathways (Debomoy K. Lahiri)]
Current Alzheimer Research Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
Current Drug Targets Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Basic Pharmacology of NMDA Receptors
Current Pharmaceutical Design The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Current Drug Targets Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach
Current Pharmaceutical Design Blood Brain Barrier in Hypoxic-Ischemic Conditions
Current Neurovascular Research Atypical Chest Pain in ACS: A Trap Especially for Women
Current Pharmaceutical Design Role of Infection Control in Prevention of Hepatitis B virus (HBV) in Hemodialysis (HD) Patients.
Infectious Disorders - Drug Targets CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders
Current Drug Targets Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction
Current HIV Research Targeting “Undruggable” Proteins: Design of Synthetic Cyclopeptides
Current Medicinal Chemistry Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Atomoxetine Protects Against NMDA Receptor-mediated Hippocampal Neuronal Death Following Transient Global Cerebral Ischemia
Current Neurovascular Research Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia
Current Neuropharmacology